Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07243184Recruiting
Polymer heart valve study for mitral valve disease
This trial is testing a new polymer artificial heart valve for people with severe mitral valve problems. It aims to see if this valve is safe and works well during surgical replacement.
BeijingAges 60 years+ - NCT07241936RecruitingPhase 1/Phase 2
Sirolimus plus ADC drugs for advanced solid tumors
This trial tests a new type of sirolimus (a targeted therapy) combined with antibody-drug conjugates (ADCs) for advanced solid tumors that haven't responded to other treatments. It aims to see if the combination can shrink tumors or slow their growth.
ShanghaiAges 18–75 - NCT07240974RecruitingEarly Phase 1
Study of ZZSW-01 for B-cell blood cancers that returned or didn't respond
This trial tests a new drug called ZZSW-01 for people with certain B-cell blood cancers (like lymphoma or leukemia) that have come back or haven't gotten better after other treatments. It aims to see if the drug is safe and works against these cancers.
WuhanAges 18 years+ - NCT07244640Recruiting
Detecting Parkinson's through eye scans
This study uses a special eye camera to see if early signs of Parkinson's and similar movement disorders can be spotted in the retina. It may help doctors diagnose these conditions sooner and more easily.
Hangzhou, ZhejiangAges 40–80 - NCT06484829RecruitingPhase 1/Phase 2
New drug combo for relapsed or refractory multiple myeloma
This trial tests a new drug, purinostat mesylate, combined with pomalidomide (a chemotherapy pill) and a low-dose steroid (dexamethasone) for people with multiple myeloma that has returned or stopped responding to prior treatments. The goal is to see if this combination can help control the cancer with manageable side effects.
Chengdu, SichuanAges 18–75 - NCT06907589Recruiting
Using Technology to Diagnose and Track Parkinson's Disease
This trial uses new technology (like sensors or apps) to help diagnose and monitor Parkinson's disease early. Researchers want to see if a simple, widespread healthcare service model can improve care. Both people with Parkinson's and healthy volunteers are needed.
Bagno a Ripoli, FirenzeAges 50–80 - NCT06907927Recruiting
AI tool to help radiologists write reports
This study tests whether an artificial intelligence (AI) assistant can help less experienced radiologists write better radiology reports. If you are a radiologist with between 6 months and 10 years of experience who writes more than 10 reports each day, you may be eligible to join.
Wuhan, HubeiAges 18 years+ - NCT05530096Recruiting
Genetic test to find minimal residual myeloma in remission
This study tests a genetic technology (ClonoSeq-based) to detect very small amounts of multiple myeloma that may remain after treatment. It may help doctors better track how well treatment is working and predict how the disease responds over time.
Montreal, QuebecAges 18 years+ - NCT07232290RecruitingPhase 2
Flonoltinib for people with polycythemia vera
This study tests a new pill, flonoltinib, for people with polycythemia vera whose blood counts are hard to control and who have not responded well to or couldn't tolerate current treatments. The goal is to see if the pill can lower the number of red blood cells and reduce symptoms, potentially reducing the need for frequent blood removal procedures.
TianjinAges 18 years+ - NCT07233889Recruiting
Phosphate supplementation for low phosphate in ICU patients
This trial tests whether adding phosphate granules to feeding tubes can help raise low phosphate levels in ICU patients who are already receiving nutrition through a feeding tube.
Wuhan, HubeiAges 18–80 - NCT07232667Recruiting
Digital wellness study for active aging in Taiwan
This study uses digital devices (like an activity tracker and a sensor pad) to help older adults stay active and healthy. It is testing whether these tools can support aging well in Taiwan.
London, AlabamaAges 60 years+ - NCT07235410Recruiting
Body composition study for liver cancer patients having TACE
This trial uses deep learning to analyze body composition from scans in people with hepatocellular carcinoma (HCC) who are undergoing TACE (a treatment that blocks blood flow to the tumor). It aims to predict outcomes better and may help doctors tailor care.
Wuhan, HubeiAges 18 years+ - NCT07230743Recruiting
Using an interactive projector to reduce anxiety in children during anesthesia
This trial tests whether an interactive projector can help distract children aged 2 to 6 while they are going under anesthesia for surgery, with the goal of lowering their anxiety. It compares the projector to standard care to see if it makes the experience less stressful for the child and family.
Vitacura, Santiago MetropolitanAges 2–6 - NCT07225660Recruiting
Timing of hormone shots after stopping birth control in IVF
This trial compares starting fertility hormones right after stopping birth control pills versus waiting a few days. It aims to find out which timing leads to better egg retrieval outcomes.
Orange, ConnecticutAges 18–40 - NCT07224061Recruiting
Asthma management program using technology and care coordination
This trial uses a smartphone app and care coordination to help children ages 4–12 with uncontrolled asthma. It aims to improve asthma control and reduce symptoms by connecting clinics and schools.
The Bronx, New YorkAges 4–12 - NCT07228650Recruiting
ADHD study using smartphone and wearable tech for teens
This study follows teens with ADHD as they move toward adulthood. It uses a smartphone app and a wearable device to track behavior and predict challenges early, so better support can be provided.
LondonAges 16–17 - NCT06912386Recruiting
Ear device for period pain relief study
This trial tests a device that gently stimulates a nerve in your ear to see if it eases menstrual cramps. It may offer a drug-free option for managing period pain.
Chengdu, SichuanAges 18–45 - NCT07222787Recruiting
Testing a new spinal implant for lower back fusion
This trial tests a new spinal implant system (CORUS-LX) for fusing two lower back discs that are causing pain. It is meant for people with severe, long-lasting back or leg pain that hasn't improved with non-surgical treatments.
Scottsdale, ArizonaAges 18–80 - NCT07223177Recruiting
Testing a new oxygen monitor for infants, children, and teens
This trial is testing a new type of oxygen sensor worn on the skin to see if it works well for children and teenagers. It may help doctors get better readings of oxygen levels in the blood.
Modesto, CaliforniaAges birth–21 years - NCT07224126Recruiting
App-based therapy for hair-pulling disorder
This trial tests a mobile app (Keen2) to help people with trichotillomania (hair-pulling disorder) reduce their pulling urges. It may be a good fit if you have stable symptoms and own an iPhone.
Kent, OhioAges 18 years+ - NCT07222085Recruiting
Long-term test of a new myoelectric control strategy
This trial tests a new way to control a powered prosthetic arm called Glide control. Researchers want to see if it stays reliable over time for people who have lost part of their arm below or above the elbow.
Annapolis, MarylandAges 18 years+ - NCT07228793Recruiting
A study tracking EYS-related retinitis pigmentosa over time
This study follows people with retinitis pigmentosa caused by changes in the EYS gene over 4 years. It collects data on how the disease progresses and does not test any new treatments.
MoscowAges 14–100 - NCT06678529Recruiting
Can brain stimulation prevent confusion after hip surgery?
This study tests if a gentle, noninvasive brain stimulation called transcranial direct current stimulation (tDCS) can reduce postoperative delirium (sudden confusion) in older adults recovering from hip fracture surgery. It aims to see if tDCS is a safe, drug-free way to protect brain function.
Taiyuan, ShanxiAges 65 years+ - NCT06735898Recruiting
A combined therapy for recovery after intensive care
This trial tests a combination of CYTOFLAVIN (given as an IV and later as a pill) to help people with long-term symptoms after spending time in the ICU. It aims to improve muscle weakness, breathing, swallowing, and energy levels during later stages of rehabilitation.
Yekaterinburg, Sverdlovsk OblastAges 18 years+
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.